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are other SOx proteins responsible for S-S that remain undetected
by our antibody. We need further studies to obtain the c-DNA
clone of SOx to detect the other isoforms of the enzyme in the
keratinocyte cDNA library.
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Abundant Expression of Vasoactive Intestinal Polypeptide
Receptor VPAC2 mRNA in Human Skin
To the Editor:
Vasoactive intestinal polypeptide (VIP) is a bioactive peptide that
in¯uences many aspects of cell function and differentiation. The
28-amino acid polypeptide belongs to the glucagon/secretin
superfamily and is widely expressed in the central nervous system
and in peripheral tissues including lung and skin, where it has been
shown to have a multitude of biological functions (Dickinson and
Fleetwood-Walker, 1999). VIP is abundantly present in cutaneous
autonomic and sensory nerve ®bers (Eedy et al, 1994) where it acts
as neuromodulator and participates in the regulation of regional
blood ¯ow. As the expression and localization of VPAC2 mRNA
has not been examined so far, this study was carried out to correlate
VIP and its receptor in the human skin. Surgically resected human
skin samples (n = 24) were obtained from surplus remnants in
excess of that required for pathologic examination after informed
consent.
For mRNA in situ hybridization, VPAC2 receptor cRNA probes
were generated by a standardized protocol using the sequence
corresponding to the region spanning from TM 3±7 of the human
VPAC2 receptor from TSUP1 human T lymphoblast cDNA which
was subcloned into a speci®c vector (pGEM-T vector, Promega,
Madison, WI) (Groneberg et al, 2001a). For antisense probes,
plasmid linearization by restriction with Spe I was followed by
transcription with T7 polymerase, for sense probes, the Nco I
linearized plasmids were transcribed with SP6 polymerase (all
Roche Diagnostics, Mannheim, Germany). The probes were
checked for their integrity by TAE-agarose gel electrophoresis
and ethidium bromide staining.
The VPAC2 receptor mRNA distribution was assessed by
nonisotopic in situ hybridization using a standardized protocol
(Groneberg et al, 2001b) with 6±8 mm cryostat sections of 4%
paraformaldehyde ®xed biopsies.
High resolution interference contrast microscopy revealed
abundant staining in all areas of the biopsies (Fig 1). Positive
VPAC2 mRNA-signals were localized to the cytoplasm of
keratinocytes with a signal intensity that was maximal at the basal
zone and decreasing to super®cial layers (Fig 1A). In the deep part
of the dermis, VPAC2 mRNA hybridization signals were present in
cells of eccrine sweat glands and in cells of the germinative
epithelium, matrix, and medulla of the hair follicle (Fig 1C). Also,
positive VPAC2 mRNA hybridization signals were localized to
endothelial and mononuclear immune cells. Control hybridizations
on alternate sections with equivalent amounts of the digoxigenin
labeled sense-probe using the same hybridization conditions and
washing stringencies were unstained (Fig 1B, D).
To relate the distribution of VPAC2 mRNA to its ligand VIP,
immunohistochemical studies were carried out using mouse
polyclonal (1:1000, Biogenesis, Poole, U.K.) or monoclonal
(1:100 Charles River, Southbridge, MA) VIP-antibodies as
described before (Fischer et al, 1998) with 6±8 mm cryostat
sections and antimouse ¯uorescein-5-isocyanate antiserum (1:400,
Amersham, Braunschweig, Germany) and anti-rabbit biotin (1:200)
± strepatavidin Texas Red (1:400, Amersham) as secondary
antibodies.
Fluorescence microscopy demonstrated an abundant expression
of VIP-immunoreactivity in nerve ®bers which were found as
branching networks surrounding blood vessels, eccrine sweat
glands, and hair follicles (Fig 1E and F) and in direct contact to
VPAC2 mRNA positive cells. Controls by omitting the primary or
secondary antibodies and incubation with the preimmune serum
did not reveal speci®c immunosignals.
VIP binding sites have so far been shown in sweat glands using
unspeci®c binding techniques (Heinz-Erian et al, 1986) and in
allergic contact dermatitis (Lundeberg and Nordlind, 1999). There
is also a large body of evidence on the functional role of VIP as a
possible sensory neuropeptide in normal skin and dermatologic
disorders. VIP protein expression has been demonstrated in normal
skin of young (Eedy et al, 1994) and elderly (Abdel-Rahman et al,
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1992) people and in dermatologic disorders such as nodular prurigo
(Abadia Molina et al, 1992) or allergic contact dermatitis
(Lundeberg and Nordlind, 1999). Also the functional role of VIP
in the normal skin and in disorders like contact dermatitis
(Bondesson et al, 1996) was analyzed; however, a detailed study
of the mRNA expression of molecular distinct VIP receptors has
not been carried out.
As the molecular properties of the VIP receptors were identi®ed
in the past years, this study was designed to localize the mRNA of
the inducible VIP receptor VPAC2 in normal human skin biopsies
and resulted in abundant staining for VPAC2 mRNA in
keratinocytes. Effects of VIP on keratinocyte cultures have been
demonstrated earlier in vitro (Haegerstrand et al, 1989). This
demonstration of VPAC2 receptor mRNA in human keratinocytes
in situ supports the previous in vitro ®ndings and provides evidence
that the mode of VIP modulation of cell proliferation in
keratinocytes is mediated at least partly via the VPAC2 receptor.
This ®nding is also supported by the recent demonstration of
VPAC2 immunoreactivity in allergic contact dermatitis (Lundeberg
and Nordlind, 1999).
A dense network of VIP-IR nerve ®bers around sweat glands
and hair follicles was shown in this study, and VIP has been
reported to induce cAMP generation in human sweat glands
(Tainio, 1987). By directly localizing VPAC2 mRNA to eccrine
gland and hair follicle cells we provide ®rst evidence for the identity
of the VIP receptor subtype that is involved in VIP-induced
upregulation of eccrine sweat secretion.
VIP has been shown to be a potent relaxant of vascular smooth
muscle (Lundberg et al, 1981). As VPAC2 receptor mRNA was not
present in the vascular smooth muscle layer of cutaneous vessels,
our results indicate that VIP-induced dermal vasodilation is
mediated via a different VIP receptor or by paracrine VPAC2
stimulation. Also, the demonstration of VPAC2 mRNA in
mononuclear in¯ammatory cells is a novel ®nding with signi®cant
impact on the role of VIP in cutaneous immunomodulation, as a
multitude of functional studies have suggested an important role of
the peptide in the regulation of the immune system (Bellinger et al,
1996).
In conclusion, this study demonstrates an abundant expression of
VPAC2 mRNA in human skin that is associated to VIP
immunoreactive nerve ®bers and suggests a major participation of
the VPAC2 receptor in cutaneous VIP-signaling.
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Figure 1. Localization of VPAC2 receptor
messenger RNA and VIP immunoreactivity.
Eight micrometer cryostat sections of human skin
were subjected to nonradioactive in situ
hybridization for VPAC2 mRNA. VPAC2
mRNA hybridization signals are localized to
epidermal keratinocytes (A) and cells of the
germinative epithelium, matrix, and medulla of
the hair follicle (C). Control slides, treated with
the sense probe, did not show speci®c staining (B,
D). Immunohistochemistry for VIP resulted in
abundant staining of VIP-immunoreactive nerve
®bers that were present around sweat glands (E)
and in the subcutis (F). Scale bars: (A, B) 160 mm,
(C, D) 60 mm, (E, F) 40 mm.
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